Share
Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.
Referral Count:
 
0

Story being shared
To be sure, Caronia is important. But I think it is mistaken to believe that pharmaceutical companies will put the off-label horse before the final judicial cart comes along.
Arnie Friede, former FDA associate chief counsel and former Pfizer senior corporate counsel, writing on the Pharmalot.com Pharma blog

Or we can send an email on your behalf
You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .